Cargando…
Relative safety profiles of high dose statin regimens
Recent clinical trials recommend achieving a low-density lipoprotein cholesterol level of <100 mg/dl in high-risk and <70 mg/dl in very high risk patients. To attain these goals, however, many patients will need statins at high doses. The most frequent side effects related to the use of statin...
Autores principales: | Escobar, Carlos, Echarri, Rocio, Barrios, Vivencio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515413/ https://www.ncbi.nlm.nih.gov/pubmed/18827903 |
Ejemplares similares
-
Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
por: Barrios, Vivencio, et al.
Publicado: (2008) -
Emerging drug combinations to optimize renovascular protection and blood pressure goals
por: Escobar, Carlos, et al.
Publicado: (2012) -
Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study
por: Barrios, Vivencio, et al.
Publicado: (2023) -
Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility
por: Barrios, Vivencio, et al.
Publicado: (2010) -
Which thiazide to choose as add-on therapy for hypertension?
por: Barrios, Vivencio, et al.
Publicado: (2014)